1-4 of 4
Aliza Gardenswartz
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

High event-free (EFS) and overall survival (OS) after non-total body irradiation (TBI) conditioning and allogeneic hematopoietic cell transplantation (HCT) in next-generation-sequencing minimal residual disease (NGS-MRD) negative B-acute lymphoblastic leukemia (B-ALL): Results from the EndRAD trial (PTCTC ONC1701)

Free
Hisham Abdel-Azim, Troy Quigg, Neena Kapoor, Yueh-Yun Chi, Christine Higham, Amy Keating, Vanessa Fabrizio, Jodi Skiles, Shalini Shenoy, Sajad Khazal, Aliza Gardenswartz, Lisa Madden, Jordan Milner, Rachel Phelan, Emi Caywood, Ulrich Duffner, Jonathan Fish, Jorge Galvez Silva, Alfred Gillio, Rabi Hanna, Jeffrey Huo, Nahal Lalefar, Kris Mahadeo, Kevin McNerney, J. Gregory Dolan, Dana Salzberg, Heather Stefanski, Michael Pulsipher
Journal: Blood
Blood (2025) 146 (Supplement 1): 163.
https://doi.org/10.1182/blood-2025-163
Published: 2025
Journal Articles

Final Results of Phase I/II Trial of Mitoxantrone in Combination with Clofarabine (MITCL) in Children with Relapsed/Refractory Acute Leukemia

Free
Jessica C Hochberg, Javier Oesterheld, Aliza Gardenswartz, Liana Klejmont, Jaclyn Basso, Elizabeth Mintzer, Lauren Harrison, Michael J Borowitz, Michael R. Loken, Mitchell S Cairo
Journal: Blood
Blood (2022) 140 (Supplement 1): 6140–6141.
https://doi.org/10.1182/blood-2022-167040
Published: 2022
Journal Articles

First Reported Case Series of Concomitant Ruxolitinib and Ibrutinib for Graft-Versus-Host Disease (GVHD)

Free
Thomas A Gagliardi, Jordan Milner, Cassey Paula, Mehmet Ozkayank, Oya Levendoglu-Tugal, Jessica C. Hochberg, Jeremy Rosenblum, Aliza Gardenswartz, Mitchell S. Cairo, Amir Steinberg
Journal: Blood
Blood (2021) 138 (Supplement 1): 4885.
https://doi.org/10.1182/blood-2021-148071
Published: 2021
Journal Articles

Reducing the Burden of Chemoradiotherapy with the Combination of Brentuximab Vedotin and Rituximab with Reduced Toxicity Chemotherapy in Children, Adolescents and Young Adults with Newly Diagnosed Hodgkin Lymphoma

Free
Jessica C. Hochberg, MD, Jaclyn Basso, RN, MSN, PNP, Liana Klejmont, Pharm D, Lauren Harrison, RN, MSN, Allyson M. Flower, MD, Aliza Gardenswartz, MD, Qiuhu Shi, PhD, Perry Gerard, MD MBA, FACR, Humayan Islam, MD, Mitchell S Cairo, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 127.
https://doi.org/10.1182/blood-2019-128684
Published: 2019